Vascular risk factors and dementia How to move forward?

被引:323
作者
Viswanathan, Anand [1 ,2 ,3 ]
Rocca, Walter A. [4 ,5 ]
Tzourio, Christophe [6 ,7 ,8 ]
机构
[1] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA
[2] Massachusetts Gen Hosp, Clin Trials Unit, Boston, MA 02114 USA
[3] Harvard Univ, Sch Med, Boston, MA USA
[4] Mayo Clin, Coll Med, Div Epidemiol, Dept Hlth Sci Res, Rochester, MN USA
[5] Mayo Clin, Coll Med, Dept Neurol, Rochester, MN USA
[6] Univ Paris 06, F-75252 Paris 05, France
[7] INSERM, Unit Neuroepidemiol 708, Paris, France
[8] Hop Lariboisiere, Dept Neurol, F-75475 Paris, France
关键词
WHITE-MATTER HYPERINTENSITIES; MIDLIFE BLOOD-PRESSURE; ALZHEIMERS-DISEASE; COGNITIVE DECLINE; APOLIPOPROTEIN-E; CEREBROVASCULAR-DISEASE; BRAIN INFARCTS; STROKE; LESIONS; LIFE;
D O I
10.1212/01.wnl.0000341271.90478.8e
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
In recent years, accumulating evidence has suggested that vascular risk factors contribute to Alzheimer disease ( AD). Vascular dementia had been traditionally considered secondary to stroke and vascular disease. It has been traditionally distinguished from AD, considered to be a purely neurodegenerative form of dementia. However, in light of this more recent literature, it appears that there is a spectrum: ranging from patients with pure vascular dementia to patients with pure AD and including a large majority of patients with contributions from both Alzheimer and vascular pathologies. In this article, we discuss the impact of vascular risk factors on AD and its consequences at the individual level and at the population level by highlighting the concept of attributable risk. We then discuss the key questions and next steps involved in designing a therapeutic trial to control vascular risk factors for the prevention of dementia. Neurology (R) 2009; 72:368-374
引用
收藏
页码:368 / 374
页数:7
相关论文
共 55 条
[31]   The prevalence and severity of white matter lesions, their relationship with age, ethnicity, gender, and cardiovascular disease risk factors: The ARIC study [J].
Liao, DP ;
Cooper, L ;
Cai, JW ;
Toole, J ;
Bryan, N ;
Burke, G ;
Shahar, E ;
Nieto, J ;
Mosley, T ;
Heiss, G .
NEUROEPIDEMIOLOGY, 1997, 16 (03) :149-162
[32]   The Study on cognition and prognosis in the elderly (SCOPE): principal results of a randomized double-blind intervention trial [J].
Lithell, H ;
Hansson, L ;
Skoog, I ;
Elmfeldt, D ;
Hofman, A ;
Olofsson, B ;
Trenkwalder, P ;
Zanchetti, A .
JOURNAL OF HYPERTENSION, 2003, 21 (05) :875-886
[33]   Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people - The cardiovascular health study [J].
Longstreth, WT ;
Manolio, TA ;
Arnold, A ;
Burke, GL ;
Bryan, N ;
Jungreis, CA ;
Enright, PL ;
OLeary, D ;
Fried, L .
STROKE, 1996, 27 (08) :1274-1282
[34]   Incidence, manifestations, and predictors of brain infarcts defined by serial cranial magnetic resonance imaging in the elderly - The Cardiovascular Health Study [J].
Longstreth, WT ;
Dulberg, C ;
Manolio, TA ;
Lewis, MR ;
Beauchamp, NJ ;
O'Leary, D ;
Carr, J ;
Furberg, CD .
STROKE, 2002, 33 (10) :2376-2382
[35]   Aggregation of vascular risk factors and risk of incident Alzheimer disease [J].
Luchsinger, JA ;
Reitz, C ;
Honig, LS ;
Tang, MX ;
Shea, S ;
Mayeux, R .
NEUROLOGY, 2005, 65 (04) :545-551
[36]   Diabetes mellitus and risk of Alzheimer's disease and dementia with stroke in a multiethnic cohort [J].
Luchsinger, JA ;
Tang, MX ;
Stern, Y ;
Shea, S ;
Mayeux, R .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2001, 154 (07) :635-641
[37]  
MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939
[38]   Vascular factors predict rate of progression in Alzheimer disease [J].
Mielke, M. M. ;
Rosenberg, P. B. ;
Tschanz, J. ;
Cook, L. ;
Corcoran, C. ;
Hayden, K. M. ;
Norton, M. ;
Rabins, P. V. ;
Green, R. C. ;
Welsh-Bohmer, K. A. ;
Breitner, J. C. S. ;
Munger, R. ;
Lyketsos, C. G. .
NEUROLOGY, 2007, 69 (19) :1850-1858
[39]   THE CONSORTIUM TO ESTABLISH A REGISTRY FOR ALZHEIMERS-DISEASE (CERAD) .2. STANDARDIZATION OF THE NEUROPATHOLOGIC ASSESSMENT OF ALZHEIMERS-DISEASE [J].
MIRRA, SS ;
HEYMAN, A ;
MCKEEL, D ;
SUMI, SM ;
CRAIN, BJ ;
BROWNLEE, LM ;
VOGEL, FS ;
HUGHES, JP ;
VANBELLE, G ;
BERG, L .
NEUROLOGY, 1991, 41 (04) :479-486
[40]   Efficacy and safety of memantine in patients with mild to moderate vascular dementia -: A randomized, placebo-controlled trial (MMM 300) [J].
Orgogozo, JM ;
Rigaud, AS ;
Stöffler, A ;
Möbius, HJ ;
Forette, F .
STROKE, 2002, 33 (07) :1834-1839